Single User License
INR 161350
Site License
INR 322700
Corporate User License
INR 484050

Service Tax Additional

select a format
Price

Single User License
USD 2500
Site License
USD 5000
Corporate User License
USD 7500

Alternatively

Request a quote
Request a Customized research
Request for Sample Report





Recent Viewed Reports


Why Ken Reasearch?


Testimonials

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ... "Mohit Mittal, Consultant, KPMG Advisory Services"

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies.... "Mustafa Masood, Financial Analyst , Coldwell Banker Riyadh"

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ... "Prashant Bhagwat,General Manager, Mahindra"

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!... "Jestin Mathew, Indonesian Trade Promotion Center"

The Report was very interesting and useful for me... "Marketing Manager, Western Union Business Solutions"


Sezary Syndrome Global Clinical Trials Review, H1, 2015

Sezary Syndrome Global Clinical Trials Review, H1, 2015


  • Products Id :- GDHC2569CTIDB
  • |
  • Pages: 91
  • |
  • February 2015
  • |
  • |
  Request for Sample Report

Executive Summary

Sezary Syndrome Global Clinical Trials Review, H1, 2015

GlobalData's clinical trial report, "Sezary Syndrome Global Clinical Trials Review, H1, 2015" provides data on the Sezary Syndrome clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Sezary Syndrome. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Sezary Syndrome. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each

Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type

Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons To Buy

Understand the dynamics of a particular indication in a condensed manner

Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more

Obtain discontinued trial listing for trials across the globe

Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 5

Introduction 6

Sezary Syndrome 6

Report Guidance 6

Clinical Trials by Region 7

Clinical Trials and Average Enrollment by Country 8

Top Countries Contributing to Clinical Trials in Asia-Pacific 10

Top Five Countries Contributing to Clinical Trials in Europe 11

Top Countries Contributing to Clinical Trials in North America 12

Top Countries Contributing to Clinical Trials in Central and South America 13

Clinical Trials by G7 Countries: Proportion of Sezary Syndrome to Oncology Clinical Trials 14

Clinical Trials by Phase in G7 Countries 15

Clinical Trials in G7 Countries by Trial Status 16

Clinical Trials by E7 Countries: Proportion of Sezary Syndrome to Oncology Clinical Trials 17

Clinical Trials by Phase 18

In Progress Trials by Phase 19

Clinical Trials by Trial Status 20

Clinical Trials by End Point Status 21

Unaccomplished Trials of Sezary Syndrome 22

Subjects Recruited Over a Period of Time 26

Clinical Trials by Sponsor Type 27

Prominent Sponsors 28

Top Companies Participating in Sezary Syndrome Therapeutics Clinical Trials 29

Prominent Drugs 30

Clinical Trial Profiles 31

Clinical Trial Overview of Top Companies 31

Eisai Co., Ltd. 31

Clinical Trial Overview of Eisai Co., Ltd. 31

Merck & Co., Inc. 32

Clinical Trial Overview of Merck & Co., Inc. 32

Shionogi & Co., Ltd. 33

Clinical Trial Overview of Shionogi & Co., Ltd. 33

Kirin Holdings Company, Limited 34

Clinical Trial Overview of Kirin Holdings Company, Limited 34

OncoSec Medical Inc. 35

Clinical Trial Overview of OncoSec Medical Inc. 35

Janssen Global Services, LLC 36

Clinical Trial Overview of Janssen Global Services, LLC 36

Emergent BioSolutions Inc. 37

Clinical Trial Overview of Emergent BioSolutions Inc. 37

arGEN-X BV 38

Clinical Trial Overview of arGEN-X BV 38

Angimmune LLC 39

Clinical Trial Overview of Angimmune LLC 39

Clinical Trial Overview of Top Institutes / Government 40

National Cancer Institute 40

Clinical Trial Overview of National Cancer Institute 40

Fred Hutchinson Cancer Research Center 42

Clinical Trial Overview of Fred Hutchinson Cancer Research Center 42

Northwestern University 45

Clinical Trial Overview of Northwestern University 45

University of Washington 46

Clinical Trial Overview of University of Washington 46

Case Comprehensive Cancer Center 47

Clinical Trial Overview of Case Comprehensive Cancer Center 47

City of Hope 48

Clinical Trial Overview of City of Hope 48

Stanford University 49

Clinical Trial Overview of Stanford University 49

Roswell Park Cancer Institute 50

Clinical Trial Overview of Roswell Park Cancer Institute 50

Mayo Clinic 51

Clinical Trial Overview of Mayo Clinic 51

Comprehensive Cancer Center of Wake Forest University 52

Clinical Trial Overview of Comprehensive Cancer Center of Wake Forest University 52

Five Key Clinical Profiles 53

Appendix 89

Abbreviations 89

Definitions 89

Research Methodology 90

Secondary Research 90

About GlobalData 91

Contact Us 91

Disclaimer 91

Source 91

List of Figures

Sezary Syndrome Therapeutics, Global, Clinical Trials by Region (%), 2015* 7

Sezary Syndrome Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8

Sezary Syndrome Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9

Sezary Syndrome Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2015* 10

Sezary Syndrome Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11

Sezary Syndrome Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 12

Proportion of Sezary Syndrome to Oncology Clinical Trials, G7 Countries (%), 2015* 14

Sezary Syndrome Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 15

Sezary Syndrome Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 16

Proportion of Sezary Syndrome to Oncology Clinical Trials, E7 Countries (%), 2015* 17

Sezary Syndrome Therapeutics, Global, Clinical Trials by Phase (%), 2015* 18

Sezary Syndrome Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 19

Sezary Syndrome Therapeutics, Global, Clinical Trials by Trial Status, 2015* 20

Sezary Syndrome Therapeutics Clinical Trials, Global, by End Point Status, 2015* 21

Sezary Syndrome Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 26

Sezary Syndrome Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 27

Sezary Syndrome Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 28

Sezary Syndrome Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 29

Sezary Syndrome Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 30

GlobalData Methodology 90

List of Tables

Sezary Syndrome Therapeutics, Global, Clinical Trials by Region, 2015* 7

Sezary Syndrome Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8

Sezary Syndrome Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9

Sezary Syndrome Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2015* 10

Sezary Syndrome Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11

Sezary Syndrome Therapeutics Clinical Trials, North America, Top Countries, 2015* 12

Sezary Syndrome Therapeutics Clinical Trials, Central and South America, Top Countries, 2015* 13

Proportion of Sezary Syndrome to Oncology Clinical Trials, G7 Countries (%), 2015* 14

Sezary Syndrome Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 15

Sezary Syndrome Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 16

Proportion of Sezary Syndrome to Oncology Clinical Trials, E7 Countries (%), 2015* 17

Sezary Syndrome Therapeutics, Global, Clinical Trials by Phase, 2015* 18

Sezary Syndrome Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 19

Sezary Syndrome Therapeutics, Global, Clinical Trials by Trial Status, 2015* 20

Sezary Syndrome Therapeutics Clinical Trials, Global, by End Point Status, 2015* 21

Sezary Syndrome Therapeutics, Global, Suspended Clinical Trials, 2015* 22

Sezary Syndrome Therapeutics, Global, Withdrawn Clinical Trials, 2015* 23

Sezary Syndrome Therapeutics, Global, Terminated Clinical Trials, 2015* 24

Sezary Syndrome Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 26

Sezary Syndrome Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 27

Sezary Syndrome Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 28

Sezary Syndrome Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 29

Sezary Syndrome Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 30

Sezary Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Eisai Co., Ltd., 2015* 31

Sezary Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2015* 32

Sezary Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Shionogi & Co., Ltd., 2015* 33

Sezary Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Kirin Holdings Company, Limited, 2015* 34

Sezary Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by OncoSec Medical Inc., 2015* 35

Sezary Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Janssen Global Services, LLC, 2015* 36

Sezary Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Emergent BioSolutions Inc., 2015* 37

Sezary Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by arGEN-X BV, 2015* 38

Sezary Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Angimmune LLC, 2015* 39

Sezary Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute, 2015* 40

Sezary Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Fred Hutchinson Cancer Research Center, 2015* 42

Sezary Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Northwestern University, 2015* 45

Sezary Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Washington, 2015* 46

Sezary Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Case Comprehensive Cancer Center, 2015* 47

Sezary Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by City of Hope, 2015* 48

Sezary Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Stanford University, 2015* 49

Sezary Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Roswell Park Cancer Institute, 2015* 50

Sezary Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Mayo Clinic, 2015* 51

Sezary Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Comprehensive Cancer Center of Wake Forest University, 2015* 52

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

Sezary Syndrome Clinical Trials, Trial Designs, Subjects Recruited, Unaccomplished Trials of Sezary Syndrome, Pfizer, AstraZeneca, Novartis, GlaxoSmithKline, Sanofi, Eli Lilly and Company, Johnson & Johnson, Merck & Co., Inc, Bristol-Myers Squibb Company, Abbott Laboratories, Hoffmann-La Roche Ltd., Celgene Corporation, Daiichi Sankyo Company, Ltd., Bayer AG, Eisai Inc., GE Healthcare, Biogen Idec Inc., Copharos Inc., Wyeth Pharmaceuticals Inc., National Cancer Center, The University of Texas, M.D. Andersons, Vanderbilt Medical Center, Memorial Sloan Kettering Cancer Center, Cancer Research UK, North Central Cancer Group, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Fred Hutchinson Cancer Research Center, European Organization for Research and Treatment of Cancer, Dana-Farber Cancer Institute, The Cancer and Leukemia Group B, Columbia University, UCLA's Jonsson Comprehensive Cancer Center, Case Comprehensive Cancer Center, Mayo Clinic, Duke University, Ohio State University, National Cancer Center, University of Pennsylvania.


Related Products in vertical
Ken Research Pvt. Ltd. 27A, Tower B-2, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India
+91 1244230204

download

Company Brochure

Engage with Us

query [@] kenresearch.com